Evidence-Based Reviews
Evidence-Based Reviews
Is it Alzheimer’s? How to pare down the possibilities
A clinical guide to rule out other dementing diseases and rare reversible causes.
Evidence-Based Reviews
Neuroleptic malignant syndrome: Answers to 6 tough questions
Empiric evidence clarifies risk factors, causes, and first-line interventions.
Evidence-Based Reviews
Video games: When does play become pathology?
Most kids have fun and don’t get ‘hooked,’ but some boys may be at particular risk.
Evidence-Based Reviews
Treatment-resistant insomnia? Ask yourself 8 questions
When insomnia persists, go back to the basics to discover what you might have missed.
Evidence-Based Reviews
5-step psychiatric workup of HIV patients
Differentiate AIDS-related and antiretroviral effects from psychiatric disorders.
Evidence-Based Reviews
Interoceptive cues: When ‘gut feelings’ point to anxiety
Exploring patients’ somatic experiences can help expose their unconscious fears.
Evidence-Based Reviews
Modafinil: Not just for sleep disorders?
Off-label use of this stimulant might improve mood disorders, ADHD, and other conditions.
Evidence-Based Reviews
Safe use of SSRIs in young adults: How strong is evidence for new suicide warning?
Pediatric suicide rates increased in 2003-04 after the black-box warning, which has now been extended to patients age 18 to 24.
Evidence-Based Reviews
Is this child bipolar? What’s needed to improve diagnosis
With genetic and brain imaging biomarkers, early intervention could protect at-risk kids.
Evidence-Based Reviews
Antidepressants: The spectrum beyond depression
Referring to certain groups of drugs as antidepressants does them a great disservice; their potential uses range far beyond mood disorders.
Evidence-Based Reviews
Why off-label antipsychotics remain first-choice drugs for delirium
Short-term, low-dose therapy appears to be worth the risk despite black-box warning.